Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
138.00    -7.00 (-4.83%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £108.29m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

14 Oct 2009 07:00

RNS Number : 7141A
Xaar PLC
14 October 2009
 



FOR IMMEDIATE RELEASE

14 October 2009

Xaar plc

INTERIM MANAGEMENT STATEMENT

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 July 2009 to 30 September 2009.

Trading and margins for the third quarter of the year were in line with the Board's expectations and were broadly stable at the levels seen in the first and second quarters of 2009.

Launches of printing machines based on Xaar's Platform 3 technology continue, with eight of our OEM (original equipment manufacturer) customers exhibiting Platform 3 based machines at the recent Label Expo trade show held in Brussels. Sales of Platform 3 products are predominantly to customers based in Western Europe and North America and, whilst continuing to show modest growth over previous quarters, are still subject to the lengthy transition period between product launch and volume sales - a process which is exacerbated by the global recession. Sales of Xaar's other product ranges are consistent with previous periods.

The consolidation of the Group's manufacturing facilities into a single plant in HuntingdonEngland is progressing to schedule. The design and planning phase of the programme is now complete and the first production processes have been relocated successfully. The overall time frame for the project remains at two years from March 2009; the costs and benefits of the project are in line with the original plan.

The Group's balance sheet remains strong. Net cash at 30 September 2009 was £9.6m (31 December 2008: £11.0m, 30 June 2009: £10.3m) after the payment of £1.5m of dividends (2008 final: £0.9m, 2009 interim: £0.6m) in the year to date.

The Board remains satisfied with the continuing stability in trading seen in the period. The overall trading environment remains unchanged from the time of the Half Yearly Report in August 2009.  There is still a lack of forward visibility of customer orders which, together with the ongoing uncertainty in the global business environment, contribute to a level of caution when looking ahead

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Steve Liebmann or Andy Harris

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBUBDGSUBGGCX
Date   Source Headline
2nd Jun 202612:58 pmRNSTotal Voting Rights
28th May 20269:18 amRNSResult of AGM
6th May 20267:00 amRNSDirector/PDMR Shareholding
5th May 202611:36 amRNSHolding(s) in Company
30th Apr 20264:44 pmRNSHolding(s) in Company
16th Apr 20269:00 amRNSPublication of Annual Report and Notice of AGM
1st Apr 20263:43 pmRNSHolding(s) in Company
24th Mar 20267:05 amRNSFinal Results
23rd Mar 20263:33 pmRNS-RInvestor Presentation via Investor Meet Company
2nd Mar 20262:44 pmRNSTotal Voting Rights
14th Jan 20267:00 amRNSTrading Statement
5th Jan 202612:28 pmRNSTotal Voting Rights
5th Dec 20251:15 pmRNSHolding(s) in Company
1st Dec 202512:15 pmRNSTotal Voting Rights
24th Nov 202511:00 amRNSDirector/PDMR Shareholding
3rd Nov 20252:00 pmRNSTotal Voting Rights
21st Oct 20254:15 pmRNSDirector/PDMR Shareholding
13th Oct 20253:20 pmRNSHolding(s) in Company
2nd Oct 202511:10 amRNSDirector/PDMR Shareholding
2nd Oct 20258:50 amRNSDirector/PDMR Shareholding
1st Oct 20255:00 pmRNSDirector/PDMR Shareholding
1st Oct 20253:30 pmRNSTotal Voting Rights
1st Oct 202512:04 pmRNSTRADING UPDATE and NOTICE OF RESULTS
1st Sep 20254:30 pmRNSTotal Voting Rights
12th Aug 20257:00 amRNS2025 INTERIM RESULTS
5th Aug 20257:00 amRNSBoard changes
1st Aug 20253:45 pmRNSTotal Voting Rights
14th Jul 202510:00 amRNSNotice of Interim Results
7th Jul 20253:30 pmRNSBlock listing Interim Review
2nd Jul 20253:30 pmRNSTotal Voting Rights
30th Jun 20252:00 pmRNSDirector/PDMR Shareholding
3rd Jun 202510:00 amRNSTotal Voting Rights
28th May 20253:30 pmRNSResult of AGM
21st May 20251:00 pmRNSHolding(s) in Company
7th May 20253:30 pmRNSNotification of Transactions of Directors & PDMRs
2nd May 202510:30 amRNSTotal Voting Rights
15th Apr 20251:15 pmRNS2024 Annual Report and Notice of AGM
11th Apr 202512:00 pmRNSHolding(s) in Company
1st Apr 20254:15 pmRNSHolding(s) in Company
1st Apr 20253:30 pmRNSTotal Voting Rights
31st Mar 20253:45 pmRNSNotification of Transactions of Directors & PDMRs
31st Mar 20251:10 pmRNSHolding(s) in Company
28th Mar 202511:30 amRNSHolding(s) in Company
27th Mar 202511:00 amRNSHolding(s) in Company
25th Mar 20255:00 pmRNSNotification of Transactions of Directors & PDMRs
25th Mar 20257:00 amRNSFinal Results
5th Mar 202511:30 amRNSTotal Voting Rights
19th Feb 202510:30 amRNSHolding(s) in Company
10th Feb 202511:00 amRNSHolding(s) in Company
5th Feb 20254:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.